Breaking News Instant updates and real-time market news.

GPRO

GoPro

$5.57 /

-0.03 (-0.54%)

16:08
08/06/20
08/06
16:08
08/06/20
16:08

GoPro reports 372,000 paid subscribers for GoPro Plus at end Q2

GoPro's Plus subscription service ended Q2 2020 with 372,000 paid subscribers, up 5% sequentially and up 57% year-over-year, the company announced.

  • 06

    Aug

GPRO GoPro
$5.57 /

-0.03 (-0.54%)

06/29/20 JPMorgan
GoPro assumed with a Neutral at JPMorgan
06/11/20 Morgan Stanley
Morgan Stanley recommends Overweight Sonos, Underweight GoPro pair trade
04/21/20 Raymond James
Sonos Radio could drive 'meaningfully higher' multiples, says Raymond James
03/16/20 Citi
GoPro downgraded to Sell from Neutral at Citi

TODAY'S FREE FLY STORIES

Recommendations
Gentherm's relative weakness offers buying opportunity, says Argus » 08:04
09/21/20
09/21
08:04
09/21/20
08:04
THRM

Gentherm

$42.45 /

-0.92 (-2.12%)

Argus analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THRM Gentherm
$42.45 /

-0.92 (-2.12%)

THRM Gentherm
$42.45 /

-0.92 (-2.12%)

06/19/20 JPMorgan
Gentherm price target raised to $39 from $34 at JPMorgan
05/12/20 Barrington
Gentherm outperforming relative to automotive industry, says Barrington
05/11/20 Roth Capital
Gentherm assumed with a Buy at Roth Capital
04/21/20 Craig-Hallum
Gentherm price target lowered to $38 from $50 at Craig-Hallum
THRM Gentherm
$42.45 /

-0.92 (-2.12%)

Hot Stocks
Dare Bioscience receives $0.9M under current grant supplement award » 08:04
09/21/20
09/21
08:04
09/21/20
08:04
DARE

Dare Bioscience

$1.05 /

-0.015 (-1.41%)

Dare Bioscience announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DARE Dare Bioscience
$1.05 /

-0.015 (-1.41%)

DARE Dare Bioscience
$1.05 /

-0.015 (-1.41%)

09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
04/27/20 Brookline
Dare Bioscience initiated with a Buy at Brookline
03/31/20 Roth Capital
Dare Bioscience price target lowered to $4 from $6 at Roth Capital
DARE Dare Bioscience
$1.05 /

-0.015 (-1.41%)

Hot Stocks
Getty Realty CFO Danion Fielding announces intention to resign later this year » 08:03
09/21/20
09/21
08:03
09/21/20
08:03
GTY

Getty Realty

$26.50 /

-1 (-3.64%)

Getty Realty announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTY Getty Realty
$26.50 /

-1 (-3.64%)

06/08/20 JMP Securities
Getty Realty resumed with an Outperform at JMP Securities
GTY Getty Realty
$26.50 /

-1 (-3.64%)

Hot Stocks
Veritiv names Salvatore Abbate as CEO, succeeding Mary Laschinger » 08:03
09/21/20
09/21
08:03
09/21/20
08:03
VRTV

Veritiv

$15.30 /

-0.5 (-3.16%)

Veritiv has announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTV Veritiv
$15.30 /

-0.5 (-3.16%)

VRTV Veritiv
$15.30 /

-0.5 (-3.16%)

03/06/20 BofA
Veritiv upgraded to Buy from Neutral at BofA
03/06/20 BofA
Veritiv upgraded to Buy from Neutral at BofA
Recommendations
Meta Financial price target raised to $27 from $25 at B. Riley FBR » 08:02
09/21/20
09/21
08:02
09/21/20
08:02
CASH

Meta Financial

$20.10 /

+0.79 (+4.09%)

B. Riley FBR analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASH Meta Financial
$20.10 /

+0.79 (+4.09%)

CASH Meta Financial
$20.10 /

+0.79 (+4.09%)

05/15/20 Raymond James
Meta Financial multi-year pact with H&R Block a positive, says Raymond James
05/15/20 Piper Sandler
Piper says Meta Financial could see 'nice capital infusion' from H&R deal
04/23/20 Raymond James
Meta Financial price target lowered to $25 from $30 at Raymond James
04/01/20 Keefe Bruyette
Meta Financial downgraded to Market Perform from Outperform at Keefe Bruyette
CASH Meta Financial
$20.10 /

+0.79 (+4.09%)

Hot Stocks
Whole Earth Brands CEO Albert Manzone appointed to board of directors » 08:02
09/21/20
09/21
08:02
09/21/20
08:02
FREE

Whole Earth Brands

$8.62 /

+0.1 (+1.17%)

Whole Earth Brands…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FREE Whole Earth Brands
$8.62 /

+0.1 (+1.17%)

FREE Whole Earth Brands
$8.62 /

+0.1 (+1.17%)

FREE Whole Earth Brands
$8.62 /

+0.1 (+1.17%)

Hot Stocks
Lexagene CEO provides update on company's progress » 08:01
09/21/20
09/21
08:01
09/21/20
08:01
LXXGF

Lexagene Holdings

$0.00 /

+ (+0.00%)

LexaGene Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

06/17/20 Brookline
Lexagene Holdings initiated with a Buy at Brookline
04/28/20 Industrial Alliance
Lexagene Holdings initiated with a Speculative Buy at Industrial Alliance
Recommendations
BlueLinx price target raised to $25 from $19 at B. Riley FBR » 08:00
09/21/20
09/21
08:00
09/21/20
08:00
BXC

BlueLinx

$18.10 /

-0.65 (-3.47%)

B. Riley FBR analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BXC BlueLinx
$18.10 /

-0.65 (-3.47%)

BXC BlueLinx
$18.10 /

-0.65 (-3.47%)

08/04/20 B. Riley FBR
B. Riley FBR upgrades BlueLinx on Q2 beat, boosts target to $19
08/04/20 B. Riley FBR
BlueLinx upgraded to Buy from Neutral at B. Riley FBR
07/15/20 B. Riley FBR
BlueLinx price target raised to $9 from $6 at B. Riley FBR
04/09/20 B. Riley FBR
BlueLinx downgraded to Neutral with $6 price target at B. Riley FBR
BXC BlueLinx
$18.10 /

-0.65 (-3.47%)

BXC BlueLinx
$18.10 /

-0.65 (-3.47%)

Options
Marriott put buyer realizes 19% same-day gains » 08:00
09/21/20
09/21
08:00
09/21/20
08:00
MAR

Marriott

$99.73 /

-4.68 (-4.48%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$99.73 /

-4.68 (-4.48%)

MAR Marriott
$99.73 /

-4.68 (-4.48%)

06:26 Today Citi
Marriott price target raised to $110 from $95 at Citi
08/17/20 Barclays
Marriott price target raised to $108 from $105 at Barclays
08/14/20
Fly Intel: Top five analyst upgrades
08/14/20 Jefferies
Marriott upgraded to Buy from Hold at Jefferies
MAR Marriott
$99.73 /

-4.68 (-4.48%)

MAR Marriott
$99.73 /

-4.68 (-4.48%)

MAR Marriott
$99.73 /

-4.68 (-4.48%)

MAR Marriott
$99.73 /

-4.68 (-4.48%)

Hot Stocks
Newmont to sell portfolio of eleven royalties to Maverix Metals for $90M » 07:59
09/21/20
09/21
07:59
09/21/20
07:59
NEM

Newmont

$64.72 /

-1.6 (-2.41%)

, MMX

Maverix Metals

$5.57 /

-0.02 (-0.36%)

Newmont (NEM) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEM Newmont
$64.72 /

-1.6 (-2.41%)

MMX Maverix Metals
$5.57 /

-0.02 (-0.36%)

NEM Newmont
$64.72 /

-1.6 (-2.41%)

09/11/20 National Bank
Newmont price target raised to C$125 from C$119 at National Bank
07/20/20 Scotiabank
Yamana downgraded to Sector Perform on valuation at Scotiabank
06/29/20 Citi
Newmont price target lowered to $70 from $74 at Citi
05/18/20 Standpoint Research
Newmont downgraded to Hold from Buy at Standpoint Research
MMX Maverix Metals
$5.57 /

-0.02 (-0.36%)

09/17/20 BMO Capital
Maverix Metals initiated with an Outperform at BMO Capital
09/16/20 CIBC
Maverix Metals price target raised to C$8 from C$7.50 at CIBC
05/19/20 Stifel
Maverix Metals price target lowered to C$7.60 from C$7.90 at Stifel
12/19/19
Fly Intel: Top five analyst initiations
NEM Newmont
$64.72 /

-1.6 (-2.41%)

  • 29
    May
NEM Newmont
$64.72 /

-1.6 (-2.41%)

NEM Newmont
$64.72 /

-1.6 (-2.41%)

Upgrade
Tilray upgraded to Hold on cost cutting progress at Jefferies » 07:58
09/21/20
09/21
07:58
09/21/20
07:58
TLRY

Tilray

$5.34 /

-0.1 (-1.84%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TLRY Tilray
$5.34 /

-0.1 (-1.84%)

TLRY Tilray
$5.34 /

-0.1 (-1.84%)

04:47 Today Jefferies
Tilray upgraded to Hold from Underperform at Jefferies
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
TLRY Tilray
$5.34 /

-0.1 (-1.84%)

TLRY Tilray
$5.34 /

-0.1 (-1.84%)

TLRY Tilray
$5.34 /

-0.1 (-1.84%)

TLRY Tilray
$5.34 /

-0.1 (-1.84%)

Hot Stocks
Maverix Metals to acquire Gold Royalty portfolio from Newmont for $75M upfront » 07:58
09/21/20
09/21
07:58
09/21/20
07:58
MMX

Maverix Metals

$5.57 /

-0.02 (-0.36%)

, NEM

Newmont

$64.72 /

-1.6 (-2.41%)

Maverix Metals (MMX) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMX Maverix Metals
$5.57 /

-0.02 (-0.36%)

NEM Newmont
$64.72 /

-1.6 (-2.41%)

MMX Maverix Metals
$5.57 /

-0.02 (-0.36%)

09/17/20 BMO Capital
Maverix Metals initiated with an Outperform at BMO Capital
09/16/20 CIBC
Maverix Metals price target raised to C$8 from C$7.50 at CIBC
05/19/20 Stifel
Maverix Metals price target lowered to C$7.60 from C$7.90 at Stifel
12/19/19
Fly Intel: Top five analyst initiations
NEM Newmont
$64.72 /

-1.6 (-2.41%)

09/11/20 National Bank
Newmont price target raised to C$125 from C$119 at National Bank
07/20/20 Scotiabank
Yamana downgraded to Sector Perform on valuation at Scotiabank
06/29/20 Citi
Newmont price target lowered to $70 from $74 at Citi
05/18/20 Standpoint Research
Newmont downgraded to Hold from Buy at Standpoint Research
NEM Newmont
$64.72 /

-1.6 (-2.41%)

  • 29
    May
NEM Newmont
$64.72 /

-1.6 (-2.41%)

NEM Newmont
$64.72 /

-1.6 (-2.41%)

Upgrade
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70 » 07:54
09/21/20
09/21
07:54
09/21/20
07:54
ACB

Aurora Cannabis

$6.54 /

-0.35 (-5.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

05:20 Today Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
09/09/20 Stifel
Aurora Cannabis price target lowered to C$10.50 from C$16 at Stifel
09/09/20 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$17.50 from C$29 at Cantor Fitzgerald
09/08/20 Ladenburg
Aurora Cannabis downgraded to Neutral at Ladenburg on slower progress
ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

ACB Aurora Cannabis
$6.54 /

-0.35 (-5.08%)

Recommendations
Amedisys price target raised to $260 from $250 at Oppenheimer » 07:51
09/21/20
09/21
07:51
09/21/20
07:51
AMED

Amedisys

$233.73 /

-1.39 (-0.59%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$233.73 /

-1.39 (-0.59%)

AMED Amedisys
$233.73 /

-1.39 (-0.59%)

09/10/20 Stephens
Amedisys price target raised to $245 from $235 at Stephens
09/02/20 BMO Capital
Amedisys price target raised to $270 from $250 at BMO Capital
07/30/20 Deutsche Bank
Amedisys price target raised to $260 from $220 at Deutsche Bank
07/30/20 Raymond James
Amedisys price target raised to $255 from $210 at Raymond James
AMED Amedisys
$233.73 /

-1.39 (-0.59%)

General news
Treasury Market Outlook: there's a big risk-off trade in the market » 07:50
09/21/20
09/21
07:50
09/21/20
07:50

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Stephens says Darden still a top pick, expects in-line Q1 comps » 07:49
09/21/20
09/21
07:49
09/21/20
07:49
DRI

Darden

$89.98 /

-1.62 (-1.77%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.98 /

-1.62 (-1.77%)

DRI Darden
$89.98 /

-1.62 (-1.77%)

06:42 Today RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
06:40 Today Wedbush
Darden downgraded to Neutral from Outperform at Wedbush on valuation
06:34 Today Wedbush
Darden downgraded to Neutral from Outperform at Wedbush
09/18/20 MKM Partners
Darden price target raised to $110 from $90 at MKM Partners
DRI Darden
$89.98 /

-1.62 (-1.77%)

  • 21
    Apr
DRI Darden
$89.98 /

-1.62 (-1.77%)

DRI Darden
$89.98 /

-1.62 (-1.77%)

DRI Darden
$89.98 /

-1.62 (-1.77%)

Conference/Events
Axsome Therapeutics to host conference call » 07:45
09/21/20
09/21
07:45
09/21/20
07:45
AXSM

Axsome Therapeutics

$81.70 /

+2.44 (+3.08%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

09/10/20 Morgan Stanley
Axsome Therapeutics initiated with an Overweight at Morgan Stanley
09/01/20 Guggenheim
Axsome's Alzheimer's agitation update better than expected, says Guggenheim
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

  • 19
    Dec
AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

AXSM Axsome Therapeutics
$81.70 /

+2.44 (+3.08%)

Hot Stocks
Adicet Bio down 13% to $18.61 after announcing 4.5M secondary offering  07:44
09/21/20
09/21
07:44
09/21/20
07:44
ACET

Adicet Bio

$18.48 /

+2.29 (+14.14%)

 
ShowHide Related Items >><<
ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

Recommendations
Coupa Software price target raised to $330 from $272 at Morgan Stanley » 07:42
09/21/20
09/21
07:42
09/21/20
07:42
COUP

Coupa Software

$248.03 /

+3.54 (+1.45%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

09/14/20 Citi
Coupa Software price target lowered to $275 from $313 at Citi
09/09/20 FBN Securities
Coupa Software price target raised to $300 from $255 at FBN Securities
09/09/20 RBC Capital
Coupa Software price target raised to $300 from $245 at RBC Capital
09/09/20 Needham
Coupa Software price target raised to $300 from $255 at Needham
COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

COUP Coupa Software
$248.03 /

+3.54 (+1.45%)

Syndicate
Adicet Bio files to sell 4.5M shares of common stock » 07:40
09/21/20
09/21
07:40
09/21/20
07:40
ACET

Adicet Bio

$18.48 /

+2.29 (+14.14%)

BofA Securities,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

ACET Adicet Bio
$18.48 /

+2.29 (+14.14%)

Earnings
Theratechnologies sees Q3 revenue $13.8M-$14.2M vs. 16.1M last year » 07:39
09/21/20
09/21
07:39
09/21/20
07:39
THTX

Theratechnologies

$2.60 /

+0.12 (+4.84%)

Revenues for the third…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

THTX Theratechnologies
$2.60 /

+0.12 (+4.84%)

Hot Stocks
Legacy Acquisition to acquire Onyx Enterprises for $20M in cash, $265M in shares » 07:38
09/21/20
09/21
07:38
09/21/20
07:38
LGC

Legacy Acquisition Corp

$10.50 /

+ (+0.00%)

Legacy Acquisition Corp…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGC Legacy Acquisition Corp
$10.50 /

+ (+0.00%)

Hot Stocks
Savaria appoints Stephen Reitknecht as CFO » 07:38
09/21/20
09/21
07:38
09/21/20
07:38
SISXF

Savaria

$0.00 /

+ (+0.00%)

Savaria Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SISXF Savaria
$0.00 /

+ (+0.00%)

08/17/20
Fly Intel: Top five analyst initiations
08/17/20 TD Securities
Savaria initiated with a Hold at TD Securities
08/14/20 Stifel
Savaria price target raised to C$18 from C$16.50 at Stifel
08/14/20 Scotiabank
Savaria price target raised to C$18 from C$16 at Scotiabank
Hot Stocks
BridgeBio's Calcilytix initiates Phase 2 study of encaleret for ADH1 » 07:37
09/21/20
09/21
07:37
09/21/20
07:37
BBIO

BridgeBio

$42.22 /

+3.8 (+9.89%)

BridgeBio Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$42.22 /

+3.8 (+9.89%)

BBIO BridgeBio
$42.22 /

+3.8 (+9.89%)

08/17/20 H.C. Wainwright
BridgeBio portfolio company granted orphan status, says H.C. Wainwright
06/25/20 BofA
BridgeBio initiated with a Neutral at BofA
06/25/20 BofA
BridgeBio initiated with a Neutral at BofA
06/05/20 Mizuho
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho
BBIO BridgeBio
$42.22 /

+3.8 (+9.89%)

  • 29
    May
Hot Stocks
MacroGenics announces $15M milestone triggered under Incyte agreement » 07:35
09/21/20
09/21
07:35
09/21/20
07:35
MGNX

MacroGenics

$31.61 /

+0.33 (+1.05%)

, INCY

Incyte

$86.83 /

-3.5 (-3.87%)

MacroGenics (MGNX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

08/03/20 Citi
MacroGenics downgraded to Neutral from Buy at Citi
06/02/20 Citi
MacroGenics price target raised to $25 from $15 at Citi
06/01/20 Guggenheim
Guggenheim upgrades MacroGenics to Buy on pipeline prospects
06/01/20 Guggenheim
MacroGenics upgraded to Buy from Neutral at Guggenheim
INCY Incyte
$86.83 /

-3.5 (-3.87%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

MGNX MacroGenics
$31.61 /

+0.33 (+1.05%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

INCY Incyte
$86.83 /

-3.5 (-3.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.